Kojin Therapeutics Revenue

Biotechnology Research • Boston, Massachusetts, United States • 1-10 Employees

Kojin Therapeutics revenue & valuation

Annual revenue	$2,400,000
Revenue per employee	$267,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$7,700,000
Total funding	$60,000,000

Key Contacts at Kojin Therapeutics

Gang Xing

Director

Wei Zhang

Director, Computational Chemistry

Vasanthi Viswanathan

Co-Founder

Harvey Berger

Chief Executive Officer

Gang Xing

Associate Director

Company overview

Headquarters	451 D St, Suite 502, Boston, Massachusetts 02210, US
Phone number	+17812997800
Website	kojintx.com
NAICS	541714
Founded	2020
Employees	1-10
Socials

About Kojin Therapeutics

Based in Boston, Massachusetts and named after the Japanese deity that tamed fire for the good of humanity, Kojin is harnessing groundbreaking discoveries in cell-state and ferroptosis biology to develop first-in-class treatments for use in patients with cancer, and autoimmune and inflammatory diseases, among other disorders. Kojin has developed a drug-discovery platform that integrates computational chemistry, structural biology, chemical biology, target-informed screening, and mechanism-driven pharmacology to discover therapeutics that specifically modulate ferroptosis, a recently discovered and characterized cell-death mechanism. The Kojin team brings together scientific leadership in chemical biology, genetics, immunology, cancer therapeutics, drug discovery, and clinical development, as well as broad experience in biotechnology entrepreneurship.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Entry

Founder/Owner

Employees by Department

Kojin Therapeutics has 5 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Kojin Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-07-09	4	$60,000,000

Funding Insights

$60,000,000

Total funding amount

$60,000,000

Most recent funding amount

Number of funding rounds

Kojin Therapeutics Tech Stack

Discover the technologies and tools that power Kojin Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Modernizr

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

PHP

Programming languages

Open Graph

Miscellaneous

Font Awesome

Font scripts

Flywheel

Hosting

GSAP

JavaScript frameworks

WordPress

Blogs

jQuery Migrate

JavaScript libraries

Frequently asked questions

Kojin Therapeutics is located in Boston, Massachusetts, US.

You can reach Kojin Therapeutics at +17812997800.

Kojin Therapeutics generates an estimated annual revenue of $2,400,000. This revenue figure reflects the company's market position and business performance in its industry.

Kojin Therapeutics has an estimated valuation of $7,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Kojin Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Kojin Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Kojin Therapeutics has raised a total of $60,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Kojin Therapeutics

Gang Xing

Director

Wei Zhang

Director, Computational Chemistry

Vasanthi Viswanathan

Co-Founder

Harvey Berger

Chief Executive Officer

Gang Xing

Associate Director

4.8